Investor actively backing innovative startups and growth-stage companies across various industries and funding rounds.
Verified emails & LinkedIn for founders across this portfolio.
Enable Biosciences is a biotech company.
Aqualung Therapeutics is developing a novel, anti-inflammatory monoclonal antibody strategy to treat serious unchecked inflammation.
AcuraStem harnesses human, patient-specific in vitro cell models and assays to develop cures and improve diagnoses in disorders of the CNS.
Novel Microdevices is a medical device startup that develops a handheld point-of-care medical device to facilitate molecular diagnostics.
Lucid Diagnostics develops a non-invasive, office based diagnostic test for biomarkers to esophageal cancer.
Annoviant is a healthcare company that develops medical devices.
Selsym Biotech is a biotechnology developer whose goal is to provide innovative platelet-mimetic therapies for the treatment.
Oxalo Therapeutics creates drugs to treat rare kidney diseases and prevent recurring kidney stones.
InVivo Biosystems specializes in genome editing and preclinical research for neurological, metabolic, and rare monogenic diseases.
CareTaker Medical develops wireless medical devices for ICU-quality remote patient monitoring and continuous Blood Pressure
Oncospherix is the culmination of a multi-year research program for cancer.
PolyCore Therapeutics’ team of life sciences scientists is dedicated to developing breakthrough treatments for CNS Diseases.
Phase Genomics develops a biotechnology platform for new discoveries in agriculture, human health, and industrial biology industries.
GelSana Therapeutics develops novel advanced polymers to improve wound healing
Wearable rehabilitation robotics
Dascena develops machine learning algorithms to enable early disease intervention and improve care outcomes for patients.
AivoCode is an emerging biotech focused on critical and highly prevalent diseases affecting the central nervous system
Myosin Therapeutics is a privately-held biopharmaceutical company developing novel medications for CNS-based disorders.
Jigsawdio is a women owned platform designed to help people with memory loss.
MAIA Biotechnology is a clinical-stage biopharmaceutical company developing cancer therapies that target telomeres through immunotherapy.
Azitra is a clinical-stage medical dermatology company developing microbiome-based novel therapeutics to treat skin conditions and diseases.
Amissa powers evidence-based perimenopause care with AI-enabled clinical decision support.
Enspectra Health is a digital transformation in pathology by imaging cellular anatomy.
Accure Health develops AI-powered, biomarker-guided solutions that enable precision therapies delivered to the right patients, right cells.
National Institutes of Health has invested in 489 companies tracked in our database. The portfolio spans multiple industries and funding stages, from seed-stage startups to late-stage companies.
National Institutes of Health's top investment sectors include Health Care, Biotechnology, Medical, Therapeutics, Medical Device. The firm invests across 27 different industry categories.
Among tracked funding rounds, Azitra received $31.0M in a Post-IPO Equity round. National Institutes of Health's total known invested capital is $2.1B.
National Institutes of Health's average investment size is $5.1M across its portfolio of 489 companies.
Recent National Institutes of Health portfolio additions include Enable Biosciences, Aqualung Therapeutics, AcuraStem, Novel Microdevices, LUCID DIAGNOSTICS INC.. These companies were founded in 2020 or later.